HOME >> MEDICINE >> NEWS
Specialist centers increase chance of surviving abdominal aortic aneurysm surgery

People with abdominal aortic aneurysms stand a better chance of surviving if they are operated on at hospitals that see large numbers of these patients than if they are treated at smaller regional hospitals with fewer such patients.

This finding is supported by two papers published in this month's BJS. Both pieces of research were led by Peter Holt, who works at St George's Hospital, London.

"Our research adds to the evidence that concentrating surgical resources in large centres of excellence can provide great benefit to patients. A bad outcome in this type of surgery is death, and specialist centres are best placed to prevent it," says Mr Holt.

An aortic aneurysm occurs when the muscle wall of the main artery that runs vertically through the body (the aortic artery) weakens and the artery bulges out irreversibly due to the blood pressure inside pushing out on the weakened segment. The wall can become extremely weak and the resulting bulge very large. If not repaired surgically, it is liable to tear (rupture) and cause catastrophic bleeding, which is fatal in 80% of cases as many patients never make it to a hospital.

The first paper reports an epidemiological study of UK data from 2000 to 2005 that investigated the outcomes of surgery on 112,545 patients. This showed that specialist centres dealing with more than 32 cases a year generate better outcomes than regional centres with lower caseloads. If the patient came in with a ruptured aneurysm the chance of survival was equally low in both regional and specialist centres.

The second paper reports a meta-analysis and systematic review that identified data, mainly from the USA, from 26 separate studies, which together involved over 350,000 patients. Peter Holt and his team concluded that a centre needed to be performing surgery on at least 43 abdominal aortic aneurysms before it could provide significantly greater chances of success. In this study, the benefit was
'"/>

Contact: Jennifer Beal
jbeal@wiley.co.uk
44-012-437-70633
John Wiley & Sons, Inc.
13-Mar-2007


Page: 1 2

Related medicine news :

1. Dr. Gutin selected as Fulbright Senior Specialist
2. 1 of 2 pediatric kidney disease research centers in world established
3. Patients with soft tissue sarcomas should be treated at high volume centers
4. Expert centers prove cost-effective in managing ovarian cancer
5. Children fare better at pediatric trauma centers
6. Medical centers vary in disclosing conflicts of interest
7. Academic medical centers face multiple challenges for conducting medical research
8. Penn study documents access to trauma centers in the United States
9. Location, access to trauma centers often inadequate, inefficient
10. Survey of academic medical centers standards for clinical-trial agreements with industry
11. Study: Level I trauma centers boost head injury survival

Post Your Comments:
(Date:5/23/2013)... Nashville, TN (PRWEB) May 23, 2013 ... to enhance nurse understanding of the professional role and ... , Roland Joy, vice president of patient care services ... explains, "TAMC nurses are excellent clinicians, and we want ... profession, teach them that to lead they must follow, ...
(Date:5/23/2013)... Portland, Oregon (PRWEB) May 23, 2013 Better ... touches as it prepares to launch its one of ... Final training of management staff will be completed May 29th, ... Chris and Heather Richardson completed on site training in Portland ... the 29th to complete operational training. , "It really is ...
(Date:5/23/2013)... PhD Box has introduced a service ... research process by offering assistance for Thesis Proposals. The proposal ... services that the company provides for research consultation in various ... proposal writing service is that this is the stage where ... process find it difficult to draft a proposal as it ...
(Date:5/23/2013)... Sunnyvale, CA (PRWEB) May 23, 2013 Footwear ... Dansko Vista Collection of sandals containing cork footbeds. ... Dansko has had consistently good sales for many years, and ... this spring and summer. , Dansko Shoes ... and the Vista Collection is no exception. Containing leather and ...
(Date:5/23/2013)... 23, 2013 Following the recent outbreak ... internet users, the security team at idcloak Technologies has ... against this or any web-born malware. Gill-Chris Welles ... provides far better privacy and security than ... that even the best AV software cannot be depended ...
Breaking Medicine News(10 mins):Health News:OnSomble, Inc. Partners with The Aroostook Medical Center to Enhance Nurse Understanding of the Professional Role 2Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Effective virus protection without anti-virus software, identifies idcloak 2
(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...
(Date:5/22/2013)... 2013 Attorney Advertising -- Bronstein, Gewirtz & ... of purchasers of the securities of AMAG Pharmaceuticals, ... The investigation focuses on whether the Company and ... On May 22, 2013, Shares of AMAG dropped ... company announced in regulatory filing that it has ...
(Date:5/22/2013)... WHITE PLAINS, N.Y. , May 22, 2013 /PRNewswire/ ... $6 million to Valor Biotherapeutics, LLC, a ... completion of pre-clinical development, manufacturing, and a Phase I ... change the poor outcomes faced by many patients with ... with rituximab. Valor,s protein, IGN002, is ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
Cached News: